HIVE Blockchain Technologies (CVE:HIV – Get Free Report) was downgraded by equities research analysts at HC Wainwright from a “buy” rating to a “neutral” rating in a research note issued to investors on Monday, PriceTargets.com reports. HC Wainwright also issued estimates for HIVE Blockchain Technologies’ Q1 2025 earnings at ($0.27) EPS, Q2 2025 earnings at ($0.34) EPS, Q3 2025 earnings at ($0.23) EPS, Q4 2025 earnings at ($0.29) EPS and FY2025 earnings at ($0.96) EPS.
HIVE Blockchain Technologies Price Performance
Recommended Stories
- Five stocks we like better than HIVE Blockchain Technologies
- How to Invest in Canada for Beginners
- The Trade Desk train returns to the station
- Insider Trades May Not Tell You What You Think
- 2 low priced AdTech stocks to ride the advertising rebound
- Airline Stocks – Top Airline Stocks to Buy Now
- The most upgraded stocks in November have two things in common
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
